Redeye comments on Smart Eye's breakthrough deal for AIS with Linde.
ChargePanel AB (publ) (”ChargePanel” eller ”bolaget”) meddelade den 26 juni att bolaget har ingått e...
Ecoclime uppvisade stark tillväxt i Q1 om 38% men resultatet var fortsatt svagt.
The Land and Environmental Court has now granted GRANGEX the permit for mining operations at Dannemo...
Marknaden är oförändrad sedan Q1-annonseringen – anpassar kostnadskostymen För att hantera de uppskj...
Redeye comments on the second interim readout with 57 evaluable patients.
Redeye briefly comments on NeoDynamics’ rights issue.
Redeye updates its estimates ahead of the Q2 report (due 21 July) with a small upward adjustments on...
Redeye retains its positive view of Transtema despite lowering our forecasts and Base Case.
Redeye updates our Biovica outlook after reporting the full 2022/23.
Redeye takes a positive view regarding the entrance of Alta Fox, a respected US-based investment fir...
Additional delays to Ovzon-3, partly due to new launch partner New date: "no earlier than late '23 o...
DT has successfully navigated through external obstacles and now has a prime opportunity to concentr...
Guides for '23e sales of SEK 65m... ... and '23e adj.
Redeye initiates coverage of Pagero, a software-as-a-service (SaaS) company that helps businesses si...
Redeye comments on the outcome of the exercise of warrants series TO 2, which was a healthy 78%, tho...
Redeye comments on Scandinavian ChemoTech’s latest supplier contract with MedVet Group and the initi...
Redeye positively views today's news that Xbrane's filing has been accepted by the FDA.
Marknadsledare i fragmenterad marknad BTS utvecklar och levererar program för förändringsarbete och ...
Lansering av SCIZYS har skjutits fram eftersom kompletteringar behöver göras.
